Single 75mg doses of netilmicin, were administered once intramuscularly to 3 healthy volunteersand 9 hospitalized patients suffering from various degrees of renal disfunction with creatinine clearance(C
cr) from 1.6 to 104ml/min, and netilmicin levels in serum and urine were determined by bioassay, and pharmacokinetic analysis were performed by the one component open model.
The maximum serum level of netilmicin(C
max) obtained from the mean serum level in the volunteers was 4.6μg/ml, the half life in serum(
t1/2) was 1.77 hrs, body serum clearance(CL
B) was 81.4ml/min, and renal clearance (CL
R) was 75.3ml/min.
The MICs of netilmicin tested clinically isolated pathogenic bacteria in Japan and the duration of the effective levels of netilmicin in serum, which was calculated from the simulated netilmicin serum levels using the pharmacokinetic parameters obtained, were compared. As the result, it was found that the following dosage regimen was established: 75 mg of netilmicin is administered every 12 hrs for the infectious disease with
S. aureus, and every 8 to 12 hrs for the infectious disease with the gram negative bacilli. Repeated administration of 75 mg of netilmicin in every 8 hrs would not induce any adverse reactions.
As renal function decreased, CL
R was decreased. The mean CL
R and
t1/2 in 3 patients with a creatinine clearance below 10ml/min. were 2.0-3.0ml/min. and 22.9hrs. respectively. The relationship between the elimination rate constant(
Kel) and C
cr was expressed as
Kel=0.0043 C
cr-0.0006. The calculated nomogram of netilmicin for the initial dose and maintenance dose in patients with various degrees of renal insufficiency, when netilmicin is administered every 8 hrs and 12 hrs, was obtained.
Serum levels in 6 subject, and urinary levels in 3 subjects were determined by radioimmunoassays (RIA) as well as by bioassays, and the both were well correlated, the correlation coefficients being 0.943 and 0.990, respectively. It may suggested that RIA method is considered to be a rapid assay method to determine the serum level of netilmicin.
View full abstract